Neurologic Disorders and COVID-19: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Agnesrinky (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} {{AE}}{{Fs}} | {{CMG}} {{AE}}{{Fs}}{{RAB}} | ||
==Overview== | ==Overview== | ||
Revision as of 23:39, 14 June 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.Rinky Agnes Botleroo, M.B.B.S.
Overview
Pathophysiology of the Complications in the Nervous System
Mechanism of targetting the Nervous System
Complications in the Central Nervous System
Cerebrovascular Accident/Stroke
- Hemorrhagic
- Ischaemic